South America Radiopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Application (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others)
Market Introduction
SAM region consists of Brazil, Argentina, and rest of SAM. Brazil led the market in 2021. Brazil is the fifth largest country in the world both by area and by population and experiencing the fastest demographic aging worldwide. In Brazil, the aging population is at a rapid pace and in a context of regional and historical socioeconomic inequalities. According to the study conducted in Brazil, the community of women estimated at the vast majority with 16.9 million (56%) of elderly persons, whereas older adults estimated approx. 13.3 million (44%). The growing aging population leads to several chronic conditions such as cancer, orthopedic conditions, neurovascular disorders, diabetes amongst others. Such growing conditions are likely to drive the adoption of medical devices, which will eventually drive the Brazil medical devices market during the forecast period. In addition, across the country, institutes are working towards the growth of the neuroscience in Brazil. For instance, The Brazilian Institute of Neuroscience and Neurotechnology (BRAINN) is a São Paulo Research Foundation (FAPESP)-funded institute that inspects the molecular mechanisms underlying epilepsy, stroke, and lesions associated with these diseases. These research activities have shown vital applications related to prevention, diagnosis, treatment for better understanding of normal and abnormal brain function. Thus, the developments in the neurological segments are expected to grow the radiopharmaceuticals Market during the forecast period.
In case of COVID-19, SAM is highly affected especially Brazil, followed by Peru, Chile, Ecuador, and Venezuela. With the outbreak of second wave COVID-19, there has been an increasing number of cases in the South American countries. According to the International Council of Nurses, the number of deaths of health professionals in Brazil are above other countries due to high transmission of the virus. Brazil has many populated regions with small houses with 6-7 people per house, the virus spreads like wildfire. Currently, the countries in this region are rapidly increasing its clinical programs to fight against the novel corona virus. In this scenario, Brazil has observed enormous difficulties in management of chronic neurological disorders, from headache to neurodegenerative diseases. Due to inadequate monitoring, many patients end up being admitted to emergency departments due to decompensation of their neurological disease. During the pandemic, stroke patients as well as other neurological conditions have been arriving late at the hospital, outside the therapeutic window for acute intervention. In addition, the country also faced difficulties in obtaining beds in the intensive care unit for management of the diseases during the acute phase. These factors are likely to have negative impact on the market growth.
Get more information on this report :
Market Overview and Dynamics
The SAM radiopharmaceuticals market is expected to grow from US$ 547.43 million in 2021 to US$ 946.54 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2021 to 2028. The use of nuclear medicine procedures is expanding rapidly, as PET and SPECT continue to improve the accuracy of detection, localization, and characterization of disease. PET and SPECT are among the nuclear medicine radiology modalities employed in clinical settings. As per the Society of Nuclear Medicine, every year, millions of nuclear medicine procedures are performed with radiopharmaceuticals and imaging instruments to diagnose disease and deliver targeted treatments in the countries across the region. These techniques have also been adopted in immunology, infection, gastroenterology, cardiology, oncology, neurology, and psychiatry, among other fields, for diagnosis and other applications. Advanced nuclear medicines and modern imaging equipment are assisting doctors in diagnosing diseases in a better manner and in less time. Continuous development of new radiopharmaceuticals for the PET/CT and SPECT/CT platforms, which are used in novel clinical applications such as neurology and orthopedics, along with the increasing accuracy of different tumor staging methods, are further contributing to the market growth. In September 2020, Curium launched Detectnet, a positron emission tomography (PET) agent, indicated for the localization of somatostatin receptor-positive neuroendocrine tumors (NETs) in adult patients. Thus, the technological advancements for improving the quality and efficacy of nuclear imaging techniques are favoring the SAM radiopharmaceuticals market growth.
Key Market Segments
In terms of type, the diagnostic nuclear medicine segment accounted for the largest share of the SAM radiopharmaceuticals market in 2020. In terms of application, the oncology segment held a larger market share of the SAM radiopharmaceuticals market in 2020. Further, the hospitals segment held a larger share of the SAM radiopharmaceuticals market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the SAM radiopharmaceuticals market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Cardinal Health Inc; Curium; GENERAL ELECTRIC; Lantheus Medical Imaging, Inc.; Bayer AG; Bracco Imaging S.p.A; and Nordion.
Reasons to buy report
- To understand the SAM radiopharmaceuticals market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for SAM radiopharmaceuticals market
- Efficiently plan M&A and partnership deals in SAM radiopharmaceuticals market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form SAM radiopharmaceuticals market
- Obtain market revenue forecast for market by various segments from 2021-2028 in SAM region.
SAM Radiopharmaceuticals Market Segmentation
SAM Radiopharmaceuticals Market - By Type
- Diagnostic Nuclear Medicine
- SPECT
- PET
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Beta Emitters
- Brachytherapy Isotopes
SAM Radiopharmaceuticals Market - By Application
- Oncology
- Cardiology
- Neurology
- Others
SAM Radiopharmaceuticals Market - By End User
- Hospitals
- Imaging Centers
- Academic and Research Centers
- Others
SAM Radiopharmaceuticals Market - By Country
- Brazil
- Argentina
- Rest of SAM
SAM Radiopharmaceuticals Market - Company Profiles
- Cardinal Health Inc
- Curium
- GENERAL ELECTRIC
- Lantheus Medical Imaging, Inc.
- Bayer AG
- Bracco Imaging S.p.A
- Nordion
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Radiopharmaceuticals Market – By Type
1.3.2 SAM Radiopharmaceuticals Market – By Application
1.3.3 SAM Radiopharmaceuticals Market – By End User
1.3.4 SAM Radiopharmaceuticals Market– By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Radiopharmaceuticals Market– Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM Radiopharmaceuticals Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Suitability of Alpha Radio Immunotherapy in Targeted Cancer Treatment.
5.1.2 Advancements in Nuclear Imaging Techniques
5.2 Market Restraints
5.2.1 Availability of Substitutes
5.3 Market Opportunities
5.3.1 High Growth Potential in Developing Countries
5.4 Future Trends
5.4.1 Use of Nuclear Medicines for Personalized Treatment
5.5 Impact Analysis
6. Radiopharmaceuticals Market– SAM Analysis
6.1 SAM Radiopharmaceuticals Market Revenue Forecast and Analysis
7. SAM Radiopharmaceuticals Market Analysis – By Type
7.1 Overview
7.2 SAM Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)
7.3 Diagnostic Nuclear Medicine
7.3.1 Overview
7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 SPECT
7.3.3.1 Overview
7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 PET
7.3.4.1 Overview
7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Therapeutic Nuclear Medicine
7.4.1 Overview
7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Alpha Emitters
7.4.3.1 Overview
7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Beta Emitters
7.4.4.1 Overview
7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Brachytherapy Isotopes
7.4.5.1 Overview
7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8. SAM Radiopharmaceuticals Market Analysis – By Application
8.1 Overview
8.2 SAM Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Cardiology
8.4.1 Overview
8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Neurology
8.5.1 Overview
8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9. SAM Radiopharmaceuticals Market Analysis – By End User
9.1 Overview
9.2 SAM Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Imaging Centres
9.4.1 Overview
9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Centers
9.5.1 Overview
9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
10. SAM Radiopharmaceuticals Market – Country Analysis
10.1 SAM: Radiopharmaceuticals Market
10.1.1 Overview
10.1.2 SAM: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
10.1.2.1 Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 Brazil Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.1 Brazil: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.1.2.2 Brazil: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.1.3 Brazil Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 Brazil Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Argentina Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.1 Argentina: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.2.2.2 Argentina: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.2.3 Argentina Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 Argentina Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Rest of SAM: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Rest of SAM: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Rest of SAM Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1 Rest of SAM: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.3.2.2 Rest of SAM: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.3.3 Rest of SAM Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Rest of SAM Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on SAM Radiopharmaceuticals Market
11.1 SAM: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Cardinal Health Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Curium
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GENERAL ELECTRIC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Lantheus Medical Imaging, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bayer AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bracco Imaging S.p.A
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Nordion
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. SAM Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Table 2. Brazil Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 5. Brazil Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 6. Brazil Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 10. Argentina Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 11. Argentina Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of SAM Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of SAM Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of SAM Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of SAM Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of SAM Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Recent Inorganic Growth Strategies
Table 18. Recent Organic Growth Strategies
Table 19. Glossary of Terms
LIST OF FIGURES
Figure 1. SAM Radiopharmaceuticals Market Segmentation
Figure 2. SAM Radiopharmaceuticals Market Segmentation, By Country
Figure 3. SAM Radiopharmaceuticals Market Overview
Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021
Figure 5. Brazil to Show Significant Growth During Forecast Period
Figure 6. SAM PEST Analysis
Figure 7. SAM Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints
Figure 8. SAM Radiopharmaceuticals Market– Revenue Forecast and Analysis
Figure 9. SAM Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)
Figure 10. SAM Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. SAM SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. SAM PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. SAM Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. SAM Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. SAM Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. SAM Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. SAM Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)
Figure 18. SAM Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. SAM Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. SAM Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. SAM Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. SAM Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)
Figure 23. SAM Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. SAM Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. SAM Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. SAM Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. SAM: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. SAM: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 29. Brazil: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
Figure 30. Argentina: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
Figure 31. Rest of SAM: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in SAM Market
- Cardinal Health Inc
- Curium
- GENERAL ELECTRIC
- Lantheus Medical Imaging, Inc.
- Bayer AG
- Bracco Imaging S.p.A
- Nordion
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM radiopharmaceuticals market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the SAM radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution